Suppr超能文献

敲低 TRIM5α 或 TRIM11 可提高人 Muller 细胞慢病毒载体转导效率。

Knockdown of TRIM5α or TRIM11 increases lentiviral vector transduction efficiency of human Muller cells.

机构信息

Department of Ophthalmology and Visual Sciences, University of Wisconsin-Madison, Madison, WI, 53706, USA.

Department of Ophthalmology and Visual Sciences, University of Wisconsin-Madison, Madison, WI, 53706, USA; Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, WI, 53706, USA; McPherson Eye Research Institute, University of Wisconsin-Madison, Madison, WI, 53706, USA.

出版信息

Exp Eye Res. 2021 Mar;204:108436. doi: 10.1016/j.exer.2021.108436. Epub 2021 Jan 10.

Abstract

The goal of this study was to determine the expression and distribution of the host restriction factors (RFs) TRIM5α and TRIM11 in non-human primate (NHP) neural retina tissue and the human Muller cell line MIO-M1. In addition, experiments were performed to determine the effect of TRIM5α and TRIM11 knockdown on FIVGFP transduction of MIO-M1 cells with the goal of devising strategies to increase the efficiency of lentiviral (LV) gene delivery. Immunofluorescence (IF) studies indicated that TRIM5α and TRIM11 were localized predominantly in nuclei within the outer nuclear layer (ONL) and inner nuclear layer (INL) of NHP retina tissue. Double label IF indicated that TRIM5α and TRIM11 were localized to some of the retinal Muller cell nuclei. MIO-M1 cells expressed TRIM5α predominantly in the nucleus and TRIM11 primarily in the cytosol. FIVGFP transduction efficiency was significantly increased, at 4 and 7 days post transduction, in TRIM5α and TRIM11 knockdown clones (KD) compared to WT MIO-M1 cells. In addition, pretreatment with the proteasome inhibitor MG132 increased the transduction efficiency of FIVGFP in WT MIO-M1 cells. The nuclear translocation of NF-κB (p65), at 72 h post FIVGFP transduction, was enhanced in TRIM5α and TRIM11 KD clones. The expression of TRIM5α and TRIM11 in macaque neural retina tissue and MIO-M1 cells indicate the presence of these RFs in NHP retina and human Muller cells. Our data indicate that even partial knockdown of TRIM5α or TRIM11, or a short proteasome inhibitor pretreatment, can increase the transduction efficiency of a LV vector.

摘要

本研究旨在确定宿主限制因子(RFs)TRIM5α 和 TRIM11 在非人类灵长类动物(NHP)神经视网膜组织和人 Muller 细胞系 MIO-M1 中的表达和分布。此外,还进行了实验以确定 TRIM5α 和 TRIM11 敲低对 MIO-M1 细胞中 FIVGFP 转导的影响,目的是设计提高慢病毒(LV)基因传递效率的策略。免疫荧光(IF)研究表明,TRIM5α 和 TRIM11 主要位于 NHP 视网膜组织的外核层(ONL)和内核层(INL)的核内。双标记 IF 表明,TRIM5α 和 TRIM11 定位于一些视网膜 Muller 细胞核内。MIO-M1 细胞主要在核内表达 TRIM5α,主要在细胞质中表达 TRIM11。与 WT MIO-M1 细胞相比,在 TRIM5α 和 TRIM11 敲低克隆(KD)中转导 4 天和 7 天后,FIVGFP 的转导效率显着提高。此外,用蛋白酶体抑制剂 MG132 预处理可增加 WT MIO-M1 细胞中 FIVGFP 的转导效率。在 FIVGFP 转导后 72 小时,TRIM5α 和 TRIM11 KD 克隆中 NF-κB(p65)的核易位增强。Macaque 神经视网膜组织和 MIO-M1 细胞中 TRIM5α 和 TRIM11 的表达表明这些 RF 存在于 NHP 视网膜和人 Muller 细胞中。我们的数据表明,即使是 TRIM5α 或 TRIM11 的部分敲低,或短暂的蛋白酶体抑制剂预处理,也可以提高 LV 载体的转导效率。

相似文献

1
Knockdown of TRIM5α or TRIM11 increases lentiviral vector transduction efficiency of human Muller cells.
Exp Eye Res. 2021 Mar;204:108436. doi: 10.1016/j.exer.2021.108436. Epub 2021 Jan 10.
2
6
Efficient transduction of human hematopoietic repopulating cells with a chimeric HIV1-based vector including SIV capsid.
Exp Hematol. 2013 Sep;41(9):779-788.e1. doi: 10.1016/j.exphem.2013.04.014. Epub 2013 May 9.
7
TRIM11 negatively regulates IFNβ production and antiviral activity by targeting TBK1.
PLoS One. 2013 May 13;8(5):e63255. doi: 10.1371/journal.pone.0063255. Print 2013.
9
The human antiviral factor TRIM11 is under the regulation of HIV-1 Vpr.
PLoS One. 2014 Aug 8;9(8):e104269. doi: 10.1371/journal.pone.0104269. eCollection 2014.
10

本文引用的文献

1
The antiviral activities of TRIM proteins.
Curr Opin Microbiol. 2021 Feb;59:50-57. doi: 10.1016/j.mib.2020.07.005. Epub 2020 Aug 20.
2
Gene Therapy in Retinal Dystrophies.
Int J Mol Sci. 2019 Nov 14;20(22):5722. doi: 10.3390/ijms20225722.
3
To TRIM or not to TRIM: the balance of host-virus interactions mediated by the ubiquitin system.
J Gen Virol. 2019 Dec;100(12):1641-1662. doi: 10.1099/jgv.0.001341.
6
Novel stem cell and gene therapy in diabetic retinopathy, age related macular degeneration, and retinitis pigmentosa.
Int J Retina Vitreous. 2019 Feb 13;5:7. doi: 10.1186/s40942-019-0158-y. eCollection 2019.
7
Adeno-Associated Viral Gene Therapy for Inherited Retinal Disease.
Pharm Res. 2019 Jan 7;36(2):34. doi: 10.1007/s11095-018-2564-5.
8
The Trim family of genes and the retina: Expression and functional characterization.
PLoS One. 2018 Sep 12;13(9):e0202867. doi: 10.1371/journal.pone.0202867. eCollection 2018.
9
Variation at the TRIM11 locus modifies progressive supranuclear palsy phenotype.
Ann Neurol. 2018 Oct;84(4):485-496. doi: 10.1002/ana.25308. Epub 2018 Sep 15.
10
Seeing the Light after 25 Years of Retinal Gene Therapy.
Trends Mol Med. 2018 Aug;24(8):669-681. doi: 10.1016/j.molmed.2018.06.006. Epub 2018 Jul 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验